Publication | Open Access

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer

Metastatic Breast CancerBreast OncologyPhase Ii TrialMedicinePharmacologyBreast CancerPharmacotherapyCancer TreatmentFirst-line ChemotherapyOncology